# Considerations When Transferring Clinical Investigation Oversight to Another IRB:  Guidance for IRBs, Clinical Investigators, and Sponsors - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/considerations-when-transferring-clinical-investigation-oversight-to-another-irb-guidance-for-irbs-clinical-investigators-and-sponsors/fe8296e5-3ca7-4209-9920-27aa4635ee35

> FDA guidance document: Considerations When Transferring Clinical Investigation Oversight to Another IRB:  Guidance for IRBs, Clinical Investigators, and Sponsors. Issue date: May 23, 2014. Get complete insights and analysis.

---

## Details

- Title: Considerations When Transferring Clinical Investigation Oversight to Another IRB:  Guidance for IRBs, Clinical Investigators, and Sponsors
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2014-05-23
- Last Changed: 2020-05-07
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2011-D-0835">FDA-2011-D-0835</a>

## Related Documents

- [Financial Disclosure by Clinical Investigators:  Guidance for Clinical Investigators, Industry,and FDA Staff](https://www.globalkeysolutions.net/guidances/guidance-document/financial-disclosure-by-clinical-investigators-guidance-for-clinical-investigators-industryand-fda-staff/a2fdcaf8-673b-4e11-9017-f37e4d719af8)
- [FDA Acceptance of Foreign Clinical Studies Not Conducted Under an IND: Frequently Asked Questions:  Guidance for Industry and FDA Staff](https://www.globalkeysolutions.net/guidances/guidance-document/fda-acceptance-of-foreign-clinical-studies-not-conducted-under-an-ind-frequently-asked-questions-guidance-for-industry-and-fda-staff/5708effd-f435-4af2-bdba-f8d7590073d4)
- [IRB Continuing Review After Clinical Investigation Approval:  Guidance for IRBs, Clinical Investigators, and Sponsors](https://www.globalkeysolutions.net/guidances/guidance-document/irb-continuing-review-after-clinical-investigation-approval-guidance-for-irbs-clinical-investigators-and-sponsors/7c18de8c-1544-4b72-a67a-3a861d29c31c)